PNR Pharma expands its in-house capabilities with the addition of a UK-based warehouse

PNR are delighted to announce the MHRA approval of our new facility in Blaenau Gwent, South Wales.  We hold MIA, MIA(IMP), MS and WDA licences which allow us to expand our service offerings in line with our business growth strategy by offering secondary packaging, labelling, controlled temperature storage, distribution for clinical trials and expanded access, as well as importation of clinical and commercial supplies. The new UK warehouse is a strategic move that ensures a more efficient and streamlined process for PNR Pharma’s operations within the UK and EU.